How does Curcuma phaeocaulis work to break up blood stasis?

Curcuma phaeocaulis contains active compounds including curzerenone, curcumol, germacrone, and furanodiene, which promote blood circulation and reduce blood stasis. These compounds demonstrate antiplatelet and anticoagulant properties that help 'move blood' in traditional Chinese medicine terms. Research suggests curcumol and germacrone may inhibit platelet aggregation and improve microcirculation. The herb also shows potential antitumor activity, possibly through apoptosis induction. Evidence level: C (preclinical and traditional use data).

Can I take Curcuma phaeocaulis with blood thinners or anticoagulants?

Curcuma phaeocaulis should not be combined with anticoagulant or antiplatelet medications. The herb contains compounds with antiplatelet properties that may enhance bleeding risk when taken with warfarin, aspirin, clopidogrel, or similar drugs. This interaction could lead to increased bruising, prolonged bleeding, or hemorrhage. Patients on blood-thinning medications should avoid this herb unless specifically directed by a qualified healthcare provider. Evidence level: C (theoretical interaction based on pharmacological activity).

What is the recommended dosage for Curcuma phaeocaulis?

The typical adult dosage of Curcuma phaeocaulis is 6-15 grams of dried rhizome daily, usually prepared as a decoction. Standardized extracts are typically taken at approximately 300mg daily. Dosage may vary based on the specific condition being treated, formulation, and individual factors. This herb should be used under guidance from a qualified traditional Chinese medicine practitioner who can adjust dosing based on your constitution and condition. Evidence level: Traditional.

Is Curcuma phaeocaulis safe to take during pregnancy?

Curcuma phaeocaulis is contraindicated during pregnancy and should be strictly avoided. As a blood-moving herb with emmenagogue properties, it stimulates blood flow and uterine contractions, which may cause miscarriage or premature labor. Traditional Chinese medicine classifies this herb as unsafe for pregnant women. Women who are pregnant, trying to conceive, or breastfeeding should not use Curcuma phaeocaulis. Evidence level: Traditional.

What conditions does Curcuma phaeocaulis treat in traditional Chinese medicine?

In traditional Chinese medicine, Curcuma phaeocaulis is primarily used to break up blood stasis and treat conditions related to blood stagnation. Common applications include amenorrhea (absent menstruation), dysmenorrhea (painful periods), abdominal masses, ovarian cysts, and menstrual pain. The herb is also traditionally used for certain types of tumors where blood stasis is identified as part of the pathology. It should only be used when blood stasis is present, not in cases of deficiency without stasis. Evidence level: C (traditional use with limited clinical trials).

Curcuma phaeocaulis (Curcuma phaeocaulis)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Curcuma phaeocaulis is a medicinal herb used in traditional Chinese medicine for treating cancer, gynecological diseases, and inflammatory conditions [PMID:40377003, 39800242, 25044589].

Contexte

Curcuma phaeocaulis Valeton is a rhizomatous herbaceous perennial plant of the Zingiberaceae family [PMID:33889750]. Its dried rhizome is known in China as Ezhu or Wen-E-Zhu and is a source of Curcumae Rhizoma [PMID:40734908, 39800242, 39102903].

Usages traditionnels

Traditionally used in Chinese medicine to treat triple-negative breast cancer [PMID:40377003], cancer and gynecological diseases [PMID:39800242], and for promoting blood circulation, dissolving blood stasis, reducing swelling, and alleviating pain [PMID:39800242, 39826788, 26648822].

Composés actifs

Key constituents include sesquiterpenoids (such as curcumenol, curcumol, germacrone, $\beta$-elemene, isocurcumenol, and phaeocaulisin A/D) [PMID:40377003, 40734908, 39800242, 38812199, 34366571, 35417150], curcuminoids (curcumin and demethoxycurcumin) [PMID:35408502, 40734908], diphenylheptanes [PMID:24818222], and the arabinogalactan polysaccharide CPAP-1 [PMID:41302400].

Mécanisme d'action

Mechanisms include inhibition of the SLC7A11/NF-$\kappa$B/TGF-$\beta$ pathway to promote ferroptosis in breast cancer [PMID:40377003], suppression of the NLRP3 inflammasome and caspase-1 activation [PMID:35408502], inhibition of the TLR4/MyD88/NF-$\kappa$B signaling pathway in liver injury [PMID:37778523], and blockade of the IL-6-activated JAK2/STAT3 pathway [PMID:31586702]. It also inhibits cyclooxygenase-2 (COX-2) [PMID:16786056, 25044589].

Preuves cliniques

Preuve DTriple-negative breast cancer (TNBC)

Curcumenol inhibited survival of TNBC cells, enhanced sensitivity to paclitaxel, and reduced tumor growth and lung metastasis in mouse models [PMID:40377003]

Preuve DAirway Inflammation

C. phaeocaulis suppressed caspase-1 activation and decreased IL-1$\beta$ levels and cell infiltration in nanoparticle-induced mouse models [PMID:35408502]

Preuve DEndometriosis

$\beta$-elemene and the herbal combination Sparganium stoloniferum-Curcuma phaeocaulis inhibit endometriosis progression via MAPK, STAT3, and S1P/S1PR1-Akt axis modulation [PMID:39800242, 38277707, 40523453]

Preuve DPrion Disease

Extracts decreased prion aggregation and propagation in vitro and in vivo, preventing disease onset in some mouse models [PMID:36613636, 39274884]

Preuve DAdjuvant Arthritis

Methanol extract significantly inhibited paw swelling and serum haptoglobin concentration in mice [PMID:16786056]

Preuve D

Sécurité et effets indésirables

Vinegar processing has been shown to reduce the toxicity of C. phaeocaulis, increasing the LC50 in zebrafish embryos [PMID:34027806].

Synthèse des preuves

The current evidence is based primarily on in vitro cell cultures and in vivo animal models (mice, rats, zebrafish), indicating strong pharmacological potential but lacking human clinical trial data.

Sources PubMed

1.PMID: 40377003 (2025) — Curcumenol inhibits malignant progression and promotes ferroptosis via the SLC7A11/NF‑κB/TGF‑β pathway in triple‑negative breast cancer. · International journal of molecular medicine
2.PMID: 35408502 (2022) — Curcuma phaeocaulis Inhibits NLRP3 Inflammasome in Macrophages and Ameliorates Nanoparticle-Induced Airway Inflammation in Mice. · Molecules (Basel, Switzerland)
3.PMID: 40734908 (2025) — Curcumae Rhizoma: An anti-cancer traditional Chinese medicine. · Chinese herbal medicines
4.PMID: 35417150 (2022) — Asymmetric Total Synthesis of (-)-Phaeocaulisin A. · Journal of the American Chemical Society
5.PMID: 39800242 (2025)

Curcuma phaeocaulis

Sources et citations